Burnham Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$1.18M Sell
35,258
-8,361
-19% -$267K 0.33% 64
2016
Q1
$1.24M Sell
43,619
-3,795
-8% -$108K 0.4% 70
2015
Q4
$1.45M Sell
47,414
-2,028
-4% -$63.8K 0.4% 69
2015
Q3
$1.47M Sell
49,442
-2,450
-5% -$78.6K 0.39% 67
2015
Q2
$1.65M Sell
51,892
-131
-0.3% -$4.27K 0.38% 68
2015
Q1
$1.72M Sell
52,023
-455
-0.9% -$14.5K 0.39% 66
2014
Q4
$1.55M Buy
52,478
+758
+1% +$21.7K 0.35% 74
2014
Q3
$1.45M Hold
51,720
0.32% 83
2014
Q2
$1.46M Buy
51,720
+150
+0.3% +$4.28K 0.32% 82
2014
Q1
$1.57M Sell
51,570
-2,423
-4% -$72.2K 0.37% 72
2013
Q4
$1.57M Sell
53,993
-63,888
-54% -$1.86M 0.37% 75
2013
Q3
$3.21M Sell
117,881
-7,393
-6% -$201K 0.8% 34
2013
Q2
$3.33M Buy
+125,274
New +$3.46M 0.85% 33

Other funds holding PFE

Burnham Asset Management's PFE Position: Q2 2016 in Review

Burnham Asset Management reduced its Pfizer (PFE) stake by 19% in Q2 2016, selling an estimated $267K and leaving 35,258 shares worth $1.18M. The position accounts for 0.33% of the portfolio, ranked #64.

Burnham Asset Management first reported a position in PFE in Q2 2013 and has held it in 13 quarters since. The position peaked at $3.33M in Q2 2013. 1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

  • Burnham Asset Management held 35,258 shares of Pfizer worth $1.18M as of Q2 2016.
  • Burnham Asset Management sold 8,361 Pfizer shares in Q2 2016, an estimated $267K.
  • Pfizer made up 0.33% of Burnham Asset Management's portfolio in Q2 2016, its #64 holding.
  • Burnham Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 13 quarters since.
  • Burnham Asset Management's Pfizer position peaked at $3.33M in Q2 2013.
  • 1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Burnham Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.